![Claudine Bruck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 35 864 $ in data 31/08/2026
Claudine E.
Bruck was the founder of Prolifagen, Inc., founded in 2016, where the title held was Chief Executive Officer from 2016 to 2022.
Current jobs include Independent Director at Annovis Bio, Inc. since 2015, Director at Ophidion, Inc., Course Director at Institute For Translational Medicine & Therapeutics, and Chief Scientific Officer at SapVax LLC.
Former jobs include Independent Director at Navidea Biopharmaceuticals, Inc. from 2018 to 2021, Course Director at the University of Pennsylvania, Vice President & Head-Biology at Center of Excellence For External Drug Discovery from 2005 to 2008, Head-Cancer Vaccine Program at GlaxoSmithKline LLC, and Assistant Professor at Tufts University School of Medicine.
Education includes doctorates from Vrije Universiteit Brussel and Harvard Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ANNOVIS BIO INC 0,05% | 04/09/2026 | 20.851 ( 0,05% ) | 35 864 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ANNOVIS BIO, INC. | Direttore/Membro del Consiglio | 01/01/2015 |
SapVax LLC
 SapVax LLC Pharmaceuticals: MajorHealth Technology Develops cancer vaccines based on a novel self-adjuvanting peptide platform technology for immuno-oncology applications | Direttore Tecnico/Scientifico/R&S | - |
Ophidion, Inc.
 Ophidion, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics for cognitive impairment diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 14/09/2021 |
Center of Excellence For External Drug Discovery | Corporate Officer/Principal | 01/01/2008 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Navidea Biopharmaceuticals, Inc.
 Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vrije Universiteit Brussel
 Vrije Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SapVax LLC
SapVax LLC Pharmaceuticals: MajorHealth Technology Develops cancer vaccines based on a novel self-adjuvanting peptide platform technology for immuno-oncology applications | Health Technology |
Prolifagen LLC
 Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
Center of Excellence For External Drug Discovery | |
Ophidion, Inc.
Ophidion, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics for cognitive impairment diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
